1GIBBON Jr J H. Application of a mechanical heart'and lung apparatus to cardiac surgery[J]. Minnesota Medicine, 1954, 37:171 185.
2WARREN O J, SMITH A J, ALEXIOU C, et al. The inflam- matory response to cardiopulmonary bypass: part 1-Mecha- nisms of pathogenesis[J]. Journal of Cardiothoracic and Vas- cular Anesthesia, 2009,23(2) :223-231.
4TOFUKUJI M, STAHL G L, METAIS C, et al. Mesenteric dys- function after cardiopulmonary bypass: role of complement CSa[J]. The Annals of Thoracic Surgery, 2000,69(3):799-807.
5ALBRECHT E A, SARMA J V, WARD P A. Activation by CSa of endothelial cell caspase 8 and cFLIP[J]. Inflammation Research, 2009,58(1) :30-37.
6RINDER C S, SMITH M J, RINDER H M, et al. Leukocyte effects of C5a-receptor blockade during simulated extracorpo real circulation[J]. Annals of Thoracic Surgery, 2007,83 (1): 146-152.
7PAPARELLA D, SCRASCIA G, ROTUNNO C A, et al. A hiocompatible cardiopulmonary bypass strategy to reduce he- mostatic and inflammatory alterations., a randomized con- trolled trial[J]. Journal of Cardiothoracic and Vascular Anes- thesia, 2012,26(4) ..557-562.
8RASMUSSEN B S, SOLLID J, KNUDSEN L, et al. The re- lease of systemic inflammatory mediators is Independent of cardiopulmonary bypass temperature[J]. Journal of Cardiotho- racic and Vascular Anesthesia, 2007,21(2):191-196.
10NAKAMURA K, UENO T, YAMAMOTO H, et al. Rela- tionship between cerebral injury and inflammatory responses in patients undergoing cardiac surgery with cardiopulmonary by- pass[J]. Cytokine, 2005,29(3):95 104.
3CREMER J, MARTIN M, REDL H, et al. Systemic inflammatory responses syndrome after cardiac operations[J].Ann Thorac Surg, 1996,61:1714-1720.
4MACGREGOR R R, THORNER R E, WRIGHT D M. Lidocaine inhibits granuloeyte adherence and prevents granulocyte delivery to inflammatory sites[J]. Blood, 1980,56 (2) : 203- 209.
5MIKAWA K, MAEKAWA N, NISHINA K, et al. Effect of lidocaine pretreatment on endotoxin-induced lung injury in rabbits[J]. Anesthesiology, 1994,81 (3) : 689-699.
6CASEY L C. Role of cytokines in the pathogenesis of cardiop ulmonary-induced multisystem organ failure[J]. Ann Thorac Surg, 1993,56(5 Suppl) :S92-96.
7ABACILAR F, DOGAN O F, DUMAN U, et al. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass[J]. Heart Surg Forum, 2006,9(4) : E703-709.
8SEGHAYE M, DUCHATEAU J, BRUNIAUX J, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations [J].Thorac Cardiovasc Surg, 1996,111(3):545-553.
9RAU S, KOHN B, RICHTER C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis[J].Vet Clin Pathol, 2007,36(3) :253-260.
10STEINBACH G, BoLKE E, SCHULTE AM ESCH J, et al. Comparison of whole blood interleukin-8 and plasma interleu kin-8 as a predictor for sepsis in postoperative patients[J]. Clin Chim Acta, 2007,378 (1/2) : 117-121.
